Search Stock News and Analysis

https://www.schaeffersresearch.com/content/news/2019/10/16/study-fail-knocks-lly-stock-lower

10/16/2019 9:44 AM

The shares of Eli Lilly and Co (NYSE:LLY) are slipping today, thanks to a failed late-stage study of its pancreatic cancer treatment. The trial studied the effects of pegilodecakin combined with chem...

Eli Lilly Drops Despite Positive Lung Cancer Drug Data

https://www.schaeffersresearch.com/content/news/2019/09/09/eli-lilly-drops-despite-positive-lung-cancer-drug-data

9/9/2019 9:41 AM

The shares of Eli Lilly and Co (NYSE:LLY) are down 0.5% at $113.53 this morning, even after data from a recent study showed the pharmaceutical giant's experimental drug LOXO-292 shrank tumors in near...

Options Bulls Just Banked on LLY Stock's Latest Rally

https://www.schaeffersresearch.com/content/options/2019/03/04/options-bulls-just-banked-on-lly-stocks-latest-rally

3/4/2019 3:13 PM

Subscribers to Schaeffer's Weekend Trader Series service doubled their money with the Eli Lilly And Co (NYSE:LLY) April 110 call. Here's a quick look at why we expected a big upside move from the ph...

Dow Futures Jump on U.S.-China Trade Deal Reports

https://www.schaeffersresearch.com/content/ezines/2019/03/04/dow-futures-jump-on-us-china-trade-deal-reports

3/4/2019 9:16 AM

Dow Jones Industrial Average (DJI) futures are pointed confidently higher this morning, thanks to more optimistic U.S.-China trade headlines. More specifically, a Wall Street Journal report on Sunda...

Incyte Stock Dips Despite Dermatitis Drug Buzz

https://www.schaeffersresearch.com/content/news/2019/02/04/incyte-stock-dips-despite-dermatitis-drug-buzz

2/4/2019 10:32 AM

The shares of Incyte Corporation (NADSAQ:INCY) were pointed higher in pre-market trading, after the company's experimental atopic dermatitis treatment met the main goal in two late-stage studies. The...

PEOPLE ALSO SEARCH FOR